PHARMACEUTICAL PRODUCT DEVELOPMENT INC Stock Repurchase Program, Remaining Authorized Repurchase Amount (Deprecated 2014-01-31)
PHARMACEUTICAL PRODUCT DEVELOPMENT INC reported Stock Repurchase Program, Remaining Authorized Repurchase Amount (Deprecated 2014-01-31) of $60.70 million for the 9-month period ending 2011-09-30, per its 10-Q filed 2011-11-02.
Discontinued › Notes › Equity
us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount · last filed 2011-11-02
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC stock repurchase program, remaining authorized repurchase amount (deprecated 2014-01-31) for the quarter ending 2011-09-30 was $0.00.
| Period end | Stock Repurchase Program, Remaining Authorized Repurchase Amount (Deprecated 2014-01-31) 3 month | Stock Repurchase Program, Remaining Authorized Repurchase Amount (Deprecated 2014-01-31) 6 month | Stock Repurchase Program, Remaining Authorized Repurchase Amount (Deprecated 2014-01-31) 9 month |
|---|---|---|---|
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02 | $60.70M 10-Q · filed 2011-11-02 | |
| 2011-06-30 | $60.70M 10-Q · filed 2011-08-04 |